205058-28-2 Usage
Uses
Used in Pharmaceutical Synthesis:
4-PHENYL-1-PIPERIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE is used as a key building block in the synthesis of various pharmaceuticals and research chemicals. Its structural resemblance to opioid compounds makes it a valuable component in the development of new medications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-PHENYL-1-PIPERIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE is utilized for studying its potential pharmacological properties. This includes exploring its efficacy in treating pain and addiction, given its similarity to known opioid analgesics.
Used in Pain Management:
4-PHENYL-1-PIPERIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE is considered for use as a pain management agent due to its structural relationship with opioid analgesics, which are known for their potent pain-relieving effects.
Used in Addiction Treatment:
4-PHENYL-1-PIPERIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE is also being studied for its potential role in addiction treatment. Given its structural similarity to methadone, a medication used to treat opioid use disorder, 4-PHENYL-1-PIPERIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE may offer therapeutic benefits in managing addiction by potentially reducing cravings and withdrawal symptoms.
Check Digit Verification of cas no
The CAS Registry Mumber 205058-28-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,0,5 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 205058-28:
(8*2)+(7*0)+(6*5)+(5*0)+(4*5)+(3*8)+(2*2)+(1*8)=102
102 % 10 = 2
So 205058-28-2 is a valid CAS Registry Number.
InChI:InChI=1/C14H17N3O/c18-14-16-13(11-4-2-1-3-5-11)10-17(14)12-6-8-15-9-7-12/h1-5,10,12,15H,6-9H2,(H,16,18)
205058-28-2Relevant academic research and scientific papers
NOVEL HETEROCYCLIC COMPOUNDS AND USE THEREOF IN MEDICINE AND IN COSMETICS
-
Paragraph 0401; 1389, (2018/03/25)
The invention relates to novel heterocyclic compounds of general formula (I), as well as their pharmaceutically acceptable salts, and their enantiomers. The invention also relates to the use thereof as a medicinal product, preferably in the prevention and/or treatment of inflammatory diseases with a neurogenic component or use thereof as a cosmetic. The compounds of the present invention act as antagonists of the CGRP-R receptor.
Modified aminoacids, pharmaceuticals containing these compounds and method for their production
-
Example A1b), (2008/06/13)
The present invention relates to modified amino acids of general formula wherein A, Z, X, n, m, R, R2, R3, R4and R11are defined as in claims 1 to 5, their tautomers, their diastereomers, their enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them as well as their use for the production and purification of antibodies and as labelled compounds in RIA- and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.
